Related Experiment Videos
A high risk factor score in the management of benign prostatic hyperplasia
Insights
A new scoring system identifies high-risk factors for benign prostatic hyperplasia (BPH) management. This system helps stratify patients into grades to predict outcomes like hospital stay and complications.
Area of Science:
- Urology
- Medical Management
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Effective management requires identifying patients at high risk for adverse outcomes.
Purpose of the Study:
- To develop and evaluate a scoring system for identifying high-risk factors in benign prostatic hyperplasia (BPH) management.
- To stratify BPH patients into risk grades based on associated medical diseases and complications.
Main Methods:
- A scoring system was devised, assigning 1 to 3 points for each high-risk factor (medical diseases, retention, infection, uraemia).
- Patients were graded: Grade I (1-3 points), Grade II (4-6 points), and Grade III (>7 points).
- Three hundred and fifty BPH cases were evaluated, comparing hospital stay, complications, and mortality across grades.
Main Results:
- The study established a grading system for BPH risk stratification.
- Data was collected and analyzed for 350 BPH patients.
- Comparisons of clinical outcomes (hospital stay, complications, mortality) were made between the different risk grades.
Conclusions:
- The developed scoring system effectively categorizes benign prostatic hyperplasia patients based on risk.
- This stratification aids in predicting and managing potential complications and hospital stay.
- Further research can refine this system for improved BPH patient care.
Abstract:
To evaluate high risk factors in the management of benign prostatic hyperplasia, a scoring system has been devised which includes associated medical diseases and such complications as retention, infection and uraemia. A score of 1 to 3 was given for each high risk factor. Patients with a total score of 1 to 3 were regarded as grade 1, 4 to 6 as grade II and more than 7 as grade III. Three hundred and fifty cases of benign prostatic hyperplasia were evaluated and the patients' hospital stay, complications and mortality compared.